期刊
NATURE GENETICS
卷 51, 期 6, 页码 957-+出版社
NATURE PORTFOLIO
DOI: 10.1038/s41588-019-0407-x
关键词
-
资金
- Kowa
- Sanofi
- National Institute on Aging (NIA)
- National Institutes of Health (NIH)
- Michael J. Fox Foundation
- University of California Healthcare - Nestle Nutrition (Nestec)
- Metagenics
- AXA
- GlaxoSmithKline
- MSD
- Eisai
- Janssen
- Sanofi-Aventis
- Eli Lilly
- National Institute of Health
- Omthera Pharmaceuticals
- Pfizer New Zealand
- Elsai Inc.
- Dalcor Pharma UK
- CSL Behring
- AstraZeneca
- BMS
- Boehringer-Ingelheim
- Pfizer
- Roche Diagnostics - Johnson Johnson
- Novartis
- Novo Nordisk
- Gruenenthal
- MRC [MR/R023484/1, MC_UU_00007/10] Funding Source: UKRI
Chronic kidney disease (CKD) is responsible for a public health burden with multi-systemic complications. Through transancestry meta-analysis of genome-wide association studies of estimated glomerular filtration rate (eGFR) and independent replication (n = 1,046,070), we identified 264 associated loci (166 new). Of these,147 were likely to be relevant for kidney function on the basis of associations with the alternative kidney function marker blood urea nitrogen (n = 416,178). Pathway and enrichment analyses, including mouse models with renal phenotypes, support the kidney as the main target organ. A genetic risk score for lower eGFR was associated with clinically diagnosed CKD in 452,264 independent individuals. Colocalization analyses of associations with eGFR among 783,978 European-ancestry individuals and gene expression across 46 human tissues, including tubulo-interstitial and glomerular kidney compartments, identified 17 genes differentially expressed in kidney. Fine-mapping highlighted missense driver variants in 11 genes and kidney-specific regulatory variants. These results provide a comprehensive priority list of molecular targets for translational research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据